Alopecia Areata Clinical Trials
Sign Up for a Clinical Trial & Gain Access to Study-related Care!
Living with Alopecia Areata
Alopecia Areata is an autoimmune disease where the immune system mistakenly attacks hair follicles, leading to rapid patchy hair loss on the scalp, face, or body. Severe cases can progress to complete scalp hair loss (Alopecia Totalis) or full-body hair loss (Alopecia Universalis). The sudden, unpredictable nature of hair loss causes significant distress and self-esteem challenges.
Recent clinical trials have revolutionized Alopecia Areata management through targeted JAK (Janus Kinase) inhibitors. These medications interrupt the intracellular inflammatory signals that cause immune cells to attack hair follicles, allowing follicles to re-enter the active growth phase and achieve significant hair regrowth.
Key Qualification Criteria
- Age: Adults (18+) and adolescents in select pediatric protocols.
- Scalp Loss Severity: Moderate-to-severe scalp hair loss involving at least 50% hair loss (SALT score ≥ 50).
- Current Episode Duration: Current episode of hair loss lasting between 6 months and 8 years.
- Health Status: Overall good health with no active severe infections or immunosuppressive conditions.
What Happens Next
- Brief Screening: Phone call to establish hair loss pattern and timeline.
- Scalp Scoring: In-person examination and SALT scoring by research dermatologists.
- Full Study Support: Access to cutting-edge research treatments, regular safety monitoring, and earn compensation